ClinicalTrials.Veeva

Menu

The Effect of Green Tea Extract on Type 2 Diabetes With Hyperlipidemia

T

Taipei City Hospital

Status and phase

Completed
Phase 3

Conditions

Hyperlipidemia
Type 2 Diabetes

Treatments

Dietary Supplement: Placebo
Dietary Supplement: Green tea extract

Study type

Interventional

Funder types

Other

Identifiers

NCT01360567
100002-63-020
TCHIRB-971103 (Other Grant/Funding Number)
TCH-971103 (Other Grant/Funding Number)

Details and patient eligibility

About

The aim of the study is to examine whether the extract of green tea is effective on type 2 diabetes and hyperlipidemia.

Full description

Percent change Homa insulin resistance, cholesterol and triglycerol.

Enrollment

102 patients

Sex

All

Ages

20 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 20--69 years old
  • Type 2 diabetes for > one year
  • TG >= 150 mg/dl or LDL >= 100 mg/dl

Exclusion criteria

  • GPT > 80 mg/dl
  • Creatinine > 1.8 mg/dl
  • Pregnancy
  • AMI
  • Stroke
  • Operational or any not suitable patients diagnosis physician in charge

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

102 participants in 2 patient groups, including a placebo group

B formula
Placebo Comparator group
Description:
placebo
Treatment:
Dietary Supplement: Placebo
A formula
Experimental group
Description:
Green tea extract
Treatment:
Dietary Supplement: Green tea extract

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems